Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study)

Figure 5

Mean changes in KHQ domain scores from baseline to endpoint in the short-term analysis set. The endpoint is presented as a mean. Intergroup comparison by Mann-Whitney U test, NS: not significant. Intragroup comparison (versus the end of the observation period) by Wilcoxon test, ^∗𝑃<0.05, ^∗∗𝑃<0.01.